WASHINGTON, D.C. — The U.S. Department of Energy (DOE) today announced $107 million in funding for six projects in the Fusion Innovative Research Engine (FIRE) Collaboratives, and that several ...
CARDINAL Phase 1/2 trial of TERN-701 enrolling well, with multiple important milestones in 2026 Planned milestones include pivotal dose selection, EOP2 regulatory interaction in mid-2026, updated and ...
Neuphoria Therapeutics reports progress on BNC210 for anxiety disorders and MK-1167 for Alzheimer’s, with upcoming trial data anticipated. Neuphoria Therapeutics Inc. announced updates for the first ...
CARDINAL Phase 1/2 trial of TERN-701 enrolling well, with multiple important milestones in 2026 Planned milestones include pivotal dose selection, EOP2 regulatory interaction in mid-2026, updated and ...
HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--BiVACOR, Inc., a clinical-stage medical device company developing the world’s first titanium Total Artificial Heart (TAH), today announced that its TAH ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results